Showing results (11-20 of 1,114) with videos related to
Sort By:
Pageof 112
The Milbank Quarterly|March 21, 2016
Evidence and the Politics of Deimplementation: The Rise and Decline of the "Counseling and Testing" Paradigm for HIV Prevention at the US Centers for Disease Control and PreventionDavid Merritt Johns, Ronald Bayer, Amy L FairchildThe Milbank Quarterly|September 13, 2017
Comparing Generic Drug Markets in Europe and the United States: Prices, Volumes, and SpendingOlivier J Wouters, Panos G Kanavos, Martin McKEEThe Milbank Quarterly|September 13, 2017
Software-Related Recalls of Health Information Technology and Other Medical Devices: Implications for FDA Regulation of Digital HealthJay G Ronquillo, Diana M ZuckermanThe Milbank Quarterly|January 1, 1989
Studying the cost of HIV-related illnesses: reflections on the moving targetA A ScitovskyThe Milbank Quarterly|December 3, 2015
Do March-In Rights Ensure Access to Medical Products Arising From Federally Funded Research? A Qualitative StudyCarolyn L Treasure, Jerry Avorn, Aaron S KesselheimThe Milbank Quarterly|December 3, 2015
Composite Measures of Health Care Provider Performance: A Description of ApproachesMichael Shwartz, Joseph D Restuccia, Amy K RosenThe Milbank Quarterly|December 3, 2015
How Effective Are Incident-Reporting Systems for Improving Patient Safety? A Systematic Literature ReviewCharitini Stavropoulou, Carole Doherty, Paul ToseyThe Milbank Quarterly|May 3, 2022
Coverage of New Drugs in Medicare Part DHuseyin Naci, Ilias Kyriopoulos, William B Feldman, et al.The Milbank Quarterly|September 12, 2018
Diversity in Medical Device Clinical Trials: Do We Know What Works for Which Patients?Stephanie R Fox-Rawlings, Laura B Gottschalk, Laurén A Doamekpor, et al.The Milbank Quarterly|July 24, 2019
FDA Sodium Reduction Targets and the Food Industry: Are There Incentives to Reformulate? Microsimulation Cost-Effectiveness AnalysisBrendan Collins, Chris Kypridemos, Jonathan Pearson-Stuttard, et al.Pageof 112